TY - JOUR AU - Coleman, R. E. PY - 1997 DA - 1997// TI - Skeletal complications of malignancy JO - Cancer VL - 80 UR - https://doi.org/3.0.CO;2-G DO - 3.0.CO;2-G ID - Coleman1997 ER - TY - JOUR AU - Rogers, M. J. AU - Gordon, S. AU - Benford, H. L. PY - 2000 DA - 2000// TI - Cellular and molecular mechanisms of action of bisphosphonates JO - Cancer VL - 88 UR - https://doi.org/3.0.CO;2-L DO - 3.0.CO;2-L ID - Rogers2000 ER - TY - JOUR AU - Kuo, Y. C. AU - Su, C. H. AU - Liu, C. Y. AU - Chen, T. H. AU - Chen, C. P. AU - Wang, H. S. PY - 2009 DA - 2009// TI - Transforming growth factor-beta induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase JO - Int J Cancer VL - 124 UR - https://doi.org/10.1002/ijc.24263 DO - 10.1002/ijc.24263 ID - Kuo2009 ER - TY - JOUR AU - Martínez, A. S. AU - Huelsken, J. PY - 2013 DA - 2013// TI - The niche under siege: novel targets for metastasis therapy JO - J Intern Med VL - 274 UR - https://doi.org/10.1111/joim.12024 DO - 10.1111/joim.12024 ID - Martínez2013 ER - TY - JOUR AU - Coleman, R. AU - Gnant, M. AU - Morgan, G. AU - Clezardin, P. PY - 2012 DA - 2012// TI - Effects of bone-targeted agents on cancer progression and mortality JO - J Natl Cancer Inst VL - 104 UR - https://doi.org/10.1093/jnci/djs263 DO - 10.1093/jnci/djs263 ID - Coleman2012 ER - TY - JOUR AU - Kaplan, R. N. AU - Psaila, B. AU - Lyden, D. PY - 2006 DA - 2006// TI - Bone marrow cells in the “pre-metastatic niche”: within bone and beyond JO - Cancer Metastasis Rev VL - 25 UR - https://doi.org/10.1007/s10555-006-9036-9 DO - 10.1007/s10555-006-9036-9 ID - Kaplan2006 ER - TY - JOUR AU - Weilbaecher, K. N. AU - Guise, T. A. AU - McCauley, L. PY - 2011 DA - 2011// TI - Cancer to bone: a fatal attraction JO - Nat Rev Cancer VL - 11 UR - https://doi.org/10.1038/nrc3055 DO - 10.1038/nrc3055 ID - Weilbaecher2011 ER - TY - JOUR AU - Luzzi, K. J. AU - MacDonald, I. C. AU - Schmidt, E. E. PY - 1998 DA - 1998// TI - Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases JO - Am J Pathol VL - 153 UR - https://doi.org/10.1016/S0002-9440(10)65628-3 DO - 10.1016/S0002-9440(10)65628-3 ID - Luzzi1998 ER - TY - JOUR AU - Paget, S. PY - 1989 DA - 1989// TI - The distribution of secondary growths in cancer of the breast JO - Cancer Metastasis Rev VL - 8 ID - Paget1989 ER - TY - JOUR AU - Shiozawa, Y. AU - Havens, A. M. AU - Pienta, K. J. AU - Taichman, R. S. PY - 2008 DA - 2008// TI - The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites JO - Leukemia VL - 22 UR - https://doi.org/10.1038/leu.2008.48 DO - 10.1038/leu.2008.48 ID - Shiozawa2008 ER - TY - JOUR AU - Bidard, F. C. AU - Vincent-Salomon, A. AU - Gomme, S. PY - 2008 DA - 2008// TI - Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-4749 DO - 10.1158/1078-0432.CCR-07-4749 ID - Bidard2008 ER - TY - JOUR AU - Braun, S. AU - Vogl, F. D. AU - Naume, B. PY - 2005 DA - 2005// TI - A pooled analysis of bone marrow micrometastasis in breast cancer JO - N Engl J Med VL - 13 UR - https://doi.org/10.1056/NEJMoa050434 DO - 10.1056/NEJMoa050434 ID - Braun2005 ER - TY - JOUR AU - Becker, S. AU - Solomayer, E. AU - Becker-Pergola, G. AU - Wallwiener, D. AU - Fehm, T. PY - 2007 DA - 2007// TI - Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients JO - Breast Cancer Res Treat VL - 13 UR - https://doi.org/10.1007/s10549-006-9484-5 DO - 10.1007/s10549-006-9484-5 ID - Becker2007 ER - TY - JOUR AU - Meads, M. B. AU - Hazlehurst, L. A. AU - Dalton, W. S. PY - 2008 DA - 2008// TI - The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-2223 DO - 10.1158/1078-0432.CCR-07-2223 ID - Meads2008 ER - TY - JOUR AU - Gnant, M. AU - Hadji, P. PY - 2010 DA - 2010// TI - Prevention of bone metastases and management of bone health in early breast cancer JO - Breast Cancer Res VL - 12 UR - https://doi.org/10.1186/bcr2768 DO - 10.1186/bcr2768 ID - Gnant2010 ER - TY - JOUR AU - Lipton, A. AU - Chapman, J. A. AU - Demers, L. PY - 2011 DA - 2011// TI - Elevated bone turnover predicts for bone metastasis in postmenopausal breast cancer: results of NCIC CTG MA.14 JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.31.5069 DO - 10.1200/JCO.2010.31.5069 ID - Lipton2011 ER - TY - JOUR AU - Kraemer, B. AU - Rothmund, R. AU - Banys, M. PY - 2011 DA - 2011// TI - Impaired bone microenvironment: correlation between bone density and presence of disseminated tumor cells JO - Anticancer Res VL - 13 ID - Kraemer2011 ER - TY - JOUR AU - Solomayer, E. F. AU - Gebauer, G. AU - Hirnle, P. PY - 2012 DA - 2012// TI - Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mdr612 DO - 10.1093/annonc/mdr612 ID - Solomayer2012 ER - TY - JOUR AU - Hoffmann, O. AU - Aktas, B. AU - Goldnau, C. PY - 2011 DA - 2011// TI - Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer: a pilot study JO - Anticancer Res VL - 31 ID - Hoffmann2011 ER - TY - JOUR AU - Aft, R. AU - Naughton, M. AU - Trinkaus, K. PY - 2010 DA - 2010// TI - Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial JO - Lancet Oncol VL - 11 UR - https://doi.org/10.1016/S1470-2045(10)70054-1 DO - 10.1016/S1470-2045(10)70054-1 ID - Aft2010 ER - TY - STD TI - Lin AY, Park JW, Scott J, Melisko M, Goga A, Moasser M, et al. Zoledronic acid as adjuvant therapy for women with early stage breast cancer and disseminated tumor cells in bone marrow [Abstract 559]. J Clin Oncol. 2008;13:20s. ID - ref21 ER - TY - JOUR AU - Banys, M. AU - Solomayer, E. F. AU - Gebauer, G. PY - 2013 DA - 2013// TI - Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-480 DO - 10.1186/1471-2407-13-480 ID - Banys2013 ER - TY - JOUR AU - Hartkopf, A. D. AU - Taran, F. A. AU - Wallwiener, M. AU - Hahn, M. AU - Becker, S. AU - Solomayer, E. F. PY - 2014 DA - 2014// TI - Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients—results from a large single-centre analysis JO - Eur J Cancer VL - 50 UR - https://doi.org/10.1016/j.ejca.2014.06.025 DO - 10.1016/j.ejca.2014.06.025 ID - Hartkopf2014 ER - TY - JOUR AU - Winter, M. C. AU - Holen, I. AU - Coleman, R. E. PY - 2008 DA - 2008// TI - Exploring the anti-tumour activity of bisphosphonates in early breast cancer JO - Cancer Treat Rev VL - 34 UR - https://doi.org/10.1016/j.ctrv.2008.02.004 DO - 10.1016/j.ctrv.2008.02.004 ID - Winter2008 ER - TY - JOUR AU - Pluijm, G. AU - Vloedgraven, H. AU - Beek, E. AU - Wee-Pals, L. AU - Lowik, C. AU - Papapoulos, S. PY - 1996 DA - 1996// TI - Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro JO - J Clin Invest VL - 13 UR - https://doi.org/10.1172/JCI118841 DO - 10.1172/JCI118841 ID - Pluijm1996 ER - TY - JOUR AU - Boissier, S. AU - Ferreras, M. AU - Peyruchaud, O. AU - Magnetto, S. AU - Ebetino, F. H. AU - Colombel, M. PY - 2000 DA - 2000// TI - Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases JO - Cancer Res VL - 13 ID - Boissier2000 ER - TY - JOUR AU - Daubiné, F. AU - Gall, C. AU - Gasser, J. PY - 2007 DA - 2007// TI - Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis JO - J Natl Cancer Inst VL - 99 UR - https://doi.org/10.1093/jnci/djk054 DO - 10.1093/jnci/djk054 ID - Daubiné2007 ER - TY - JOUR AU - Senaratne, S. G. AU - Pirianov, G. AU - Mansi, J. L. AU - Arnett, T. R. AU - Colston, K. W. PY - 2000 DA - 2000// TI - Bisphosphonates induce apoptosis in human breast cancer cell lines JO - Br J Cancer VL - 82 UR - https://doi.org/10.1054/bjoc.1999.1131 DO - 10.1054/bjoc.1999.1131 ID - Senaratne2000 ER - TY - JOUR AU - Fournier, P. G. AU - Stresing, V. AU - Ebetino, F. H. AU - Clezardin, P. PY - 2010 DA - 2010// TI - How do bisphosphonates inhibit bone metastasis in vivo? JO - Neoplasia VL - 13 UR - https://doi.org/10.1593/neo.10282 DO - 10.1593/neo.10282 ID - Fournier2010 ER - TY - JOUR AU - Clézardin, P. PY - 2011 DA - 2011// TI - Bisphosphonates’ antitumor activity: an unravelled side of a multifaceted drug class JO - Bone VL - 48 UR - https://doi.org/10.1016/j.bone.2010.07.016 DO - 10.1016/j.bone.2010.07.016 ID - Clézardin2011 ER - TY - JOUR AU - Roelofs, A. J. AU - Thompson, K. AU - Ebetino, F. H. PY - 2010 DA - 2010// TI - Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages JO - Curr Pharm Des VL - 16 UR - https://doi.org/10.2174/138161210793563635 DO - 10.2174/138161210793563635 ID - Roelofs2010 ER - TY - JOUR AU - Karnoub, A. E. AU - Dash, A. B. AU - Vo, A. P. PY - 2007 DA - 2007// TI - Mesenchymal stem cells within tumour stroma promote breast cancer metastasis JO - Nature VL - 449 UR - https://doi.org/10.1038/nature06188 DO - 10.1038/nature06188 ID - Karnoub2007 ER - TY - JOUR AU - Gallo, M. AU - Luca, A. AU - Lamura, L. AU - Normanno, N. PY - 2012 DA - 2012// TI - Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mdr159 DO - 10.1093/annonc/mdr159 ID - Gallo2012 ER - TY - JOUR AU - Wood, J. AU - Bonjean, K. AU - Ruetz, S. AU - Bellahcene, A. AU - Devy, L. AU - Foidart, J. M. PY - 2002 DA - 2002// TI - Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid JO - J Pharmacol Exp Ther VL - 13 UR - https://doi.org/10.1124/jpet.102.035295 DO - 10.1124/jpet.102.035295 ID - Wood2002 ER - TY - JOUR AU - Santini, D. AU - Vincenzi, B. AU - Avvisati, G. PY - 2002 DA - 2002// TI - Pamidronate induces modifications of circulating angiogenetic factors in cancer patients JO - Clin Cancer Res VL - 8 ID - Santini2002 ER - TY - JOUR AU - Santini, D. AU - Vincenzi, B. AU - Dicuonzo, G. PY - 2003 DA - 2003// TI - Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients JO - Clin Cancer Res VL - 9 ID - Santini2003 ER - TY - JOUR AU - Santini, D. AU - Vincenzi, B. AU - Galluzzo, S. PY - 2007 DA - 2007// TI - Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-07-0551 DO - 10.1158/1078-0432.CCR-07-0551 ID - Santini2007 ER - TY - JOUR AU - Maniar, A. AU - Zhang, X. AU - Lin, W. PY - 2010 DA - 2010// TI - Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement JO - Blood VL - 116 UR - https://doi.org/10.1182/blood-2009-07-234211 DO - 10.1182/blood-2009-07-234211 ID - Maniar2010 ER - TY - JOUR AU - Benzaïd, I. AU - Mönkkönen, H. AU - Stresing, V. PY - 2011 DA - 2011// TI - High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-10-3862 DO - 10.1158/0008-5472.CAN-10-3862 ID - Benzaïd2011 ER - TY - JOUR AU - Syddall, S. P. AU - Ottewell, P. D. AU - Holen, I. PY - 2010 DA - 2010// TI - Combined therapies of bone disease with bisphosphonates JO - Curr Pharm Des VL - 16 UR - https://doi.org/10.2174/138161210793563590 DO - 10.2174/138161210793563590 ID - Syddall2010 ER - TY - JOUR AU - Diel, I. J. AU - Jaschke, A. AU - Solomayer, E. F. AU - Gollan, C. AU - Bastert, G. AU - Sohn, C. PY - 2008 DA - 2008// TI - Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow–a long-term follow-up JO - Ann Oncol VL - 19 UR - https://doi.org/10.1093/annonc/mdn429 DO - 10.1093/annonc/mdn429 ID - Diel2008 ER - TY - JOUR AU - Powles, T. AU - Paterson, A. AU - McCloskey, E. AU - Schein, P. AU - Scheffler, B. AU - Tidy, A. PY - 2006 DA - 2006// TI - Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer JO - Breast Cancer Res VL - 8 UR - https://doi.org/10.1186/bcr1384 DO - 10.1186/bcr1384 ID - Powles2006 ER - TY - JOUR AU - Saarto, T. AU - Vehmanen, L. AU - Virkkunen, P. AU - Blomqvist, C. PY - 2004 DA - 2004// TI - Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients JO - Acta Oncol VL - 43 UR - https://doi.org/10.1080/02841860410032885 DO - 10.1080/02841860410032885 ID - Saarto2004 ER - TY - JOUR AU - Paterson, A. H. AU - Anderson, S. J. AU - Lembersky, B. C. AU - Fehrenbacher, L. AU - Falkson, C. I. AU - King, K. M. PY - 2012 DA - 2012// TI - Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(12)70226-7 DO - 10.1016/S1470-2045(12)70226-7 ID - Paterson2012 ER - TY - JOUR AU - Brufsky, A. M. AU - Bosserman, L. D. AU - Caradonna, R. R. AU - Haley, B. B. AU - Jones, C. M. AU - Moore, H. C. PY - 2009 DA - 2009// TI - Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results JO - Clin Breast Cancer VL - 9 UR - https://doi.org/10.3816/CBC.2009.n.015 DO - 10.3816/CBC.2009.n.015 ID - Brufsky2009 ER - TY - JOUR AU - Coleman, R. AU - Boer, R. AU - Eidtmann, H. AU - Llombart, A. AU - Davidson, N. AU - Neven, P. PY - 2013 DA - 2013// TI - Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results JO - Ann Oncol VL - 24 UR - https://doi.org/10.1093/annonc/mds277 DO - 10.1093/annonc/mds277 ID - Coleman2013 ER - TY - JOUR AU - Coleman, R. E. AU - Marshall, H. AU - Cameron, D. AU - Dodwell, D. AU - Burkinshaw, R. AU - Keane, M. PY - 2011 DA - 2011// TI - Breast-cancer adjuvant therapy with zoledronic acid JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1105195 DO - 10.1056/NEJMoa1105195 ID - Coleman2011 ER - TY - STD TI - von Minckwitz G, Rezai M, Eidtmann H, et al. Post-neoadjuvant treatment with zoledronate in patients with tumor residuals after anthracyclines-taxane-based chemotherapy for primary breast cancer–the phase III NATAN study (GBG 36/ABCSG XX). [Abstract S5-05]. San Antonio Breast Cancer Symposium, San Antonio, Texas. Presented 12 Dec 2013. ID - ref48 ER - TY - STD TI - Coleman R, Gnant M, Paterson A, et al. Effects of bisphosphonate treatment on recurrence and cause-specific mortality in women with early breast cancer: a meta-analysis of individual patient data from randomized trials [Abstract S4-07]. San Antonio Breast Cancer Symposium, San Antonio, Texas. Presented 12 Dec 2013. ID - ref49 ER - TY - JOUR AU - Valachis, A. AU - Polyzos, N. P. AU - Coleman, R. E. AU - Gnant, M. PY - 2013 DA - 2013// TI - Adjuvant therapy with zoledronic acid in patients with breast cancer: a systematic review and meta-analysis JO - Oncologist VL - 18 UR - https://doi.org/10.1634/theoncologist.2012-0261 DO - 10.1634/theoncologist.2012-0261 ID - Valachis2013 ER - TY - JOUR AU - Gnant, M. AU - Mlineritsch, B. AU - Schippinger, W. AU - Luschin-Ebengreuth, G. AU - Postlberger, S. AU - Menzel, C. PY - 2009 DA - 2009// TI - Endocrine therapy plus zoledronic acid in premenopausal breast cancer JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0806285 DO - 10.1056/NEJMoa0806285 ID - Gnant2009 ER - TY - STD TI - Vidal L, Ben-Aharon I, Rizel S, et al. Bisphosphonates in the adjuvant setting of breast cancer therapy: effect on survival—a systematic review and meta-analysis. J Clin Oncol. 2012;30:Abstract 548. ID - ref52 ER - TY - JOUR AU - Ottewell, P. D. PY - 2014 DA - 2014// TI - Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-1246 DO - 10.1158/1078-0432.CCR-13-1246 ID - Ottewell2014 ER - TY - STD TI - Shepherd LE, Chapman JA, Ali SM, et al. Effect of osteoporosis in postmenopausal breast cancer patients randomized to adjuvant exemestane or anastrozole: NCIC CTG MA.27. J Clin Oncol. 2012;30:Abstract 501. ID - ref54 ER - TY - JOUR AU - Goss, P. E. AU - Ingle, J. N. AU - Pritchard, K. I. PY - 2013 DA - 2013// TI - Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27–a randomized controlled phase III trial JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.44.7805 DO - 10.1200/JCO.2012.44.7805 ID - Goss2013 ER - TY - JOUR AU - Li, L. AU - Neaves, W. B. PY - 2006 DA - 2006// TI - Normal stem cells and cancer stem cells: the niche matters JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-3986 DO - 10.1158/0008-5472.CAN-05-3986 ID - Li2006 ER - TY - JOUR AU - Gnant, M. AU - Mlineritsch, B. AU - Stoeger, H. PY - 2015 DA - 2015// TI - Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12 JO - Ann Oncol VL - 26 UR - https://doi.org/10.1093/annonc/mdu544 DO - 10.1093/annonc/mdu544 ID - Gnant2015 ER -